483 results on '"Fanciulli, Maurizio"'
Search Results
52. Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity
53. Application of RNA-Seq Technology in Cancer Chemoprevention
54. Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas
55. Review for "ARID1A ‐deficient cells require HDAC6 for progression of endometrial carcinoma"
56. Nuclear HBx Binds the HBV Minichromosome and Modifies the Epigenetic Regulation of cccDNA Function
57. AATF/Che-1, a new component of paraspeckles, controls R-loops formation and Interferon activation in Multiple Myeloma
58. Che-1 Promotes Tumor Cell Survival by Sustaining Mutant p53 Transcription and Inhibiting DNA Damage Response Activation
59. Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B
60. Novel activation domain derived from Che-1 cofactor coupled with the artificial protein Jazz drives utrophin upregulation
61. Additional file 5 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity
62. Additional file 3 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity
63. Additional file 4 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity
64. Additional file 2 of CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity
65. CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity
66. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape
67. Adjuvant Electrochemotherapy Increases Local Control in a Recurring Equine Anal Melanoma
68. Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
69. Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosis (1)
70. The artificial 4-zinc-finger protein Bagly binds human utrophin promoter A at the endogenous chromosomal site and activates transcription
71. Definition of a Novel Plasmid-Based Gene Transfection Protocol of Mammalian Skeletal Muscles by Means of In Vivo Electroporation
72. Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes
73. Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G 2/M checkpoint
74. Che-1/AATF binds to RNA polymerase I machinery and sustains ribosomal RNA gene transcription
75. B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells
76. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice
77. Rb and Tumorigenesis
78. MOESM5 of Combinations of immuno-checkpoint inhibitors predictive biomarkers only marginally improve their individual accuracy
79. Additional file 1: of Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
80. Additional file 2: of Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
81. The artificial 4-zinc-finger protein Bagly binds human utrophin promoter A at the endogenous chromosomal site and activates transcription
82. Rb binding protein Che-1 interacts with Tau in cerebellar granule neurons
83. KEAP1and TP53Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy
84. Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb
85. MOESM2 of Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
86. MOESM1 of Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
87. PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
88. Reverse Engineering Cancer: Inferring Transcriptional Gene Signatures from Copy Number Aberrations with ICAro
89. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb
90. The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response
91. Dietary Protective Effects Against Hepatocellular Carcinoma Development in Mdr2-/- Knockout Mice
92. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
93. Abstract 350: Che-1/aatf-induced transcriptionally active chromatin promotes cell growth in multiple myeloma
94. A new baby in the c-Myc-directed transcriptional machinery: Che-1/AATF
95. The clinical significance of PD-L1 in advanced gastric cancer is dependent onARID1Amutations and ATM expression
96. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
97. Conditionally reprogrammed cells (CRC) methodology does not allow thein vitroexpansion of patient-derived primary and metastatic lung cancer cells
98. Che‐1 is targeted by c‐Myc to sustain proliferation in pre‐B‐cell acute lymphoblastic leukemia
99. The RNA polymerase II core subunit 11 interacts with keratin 19, a component of the intermediate filament proteins
100. Additional file 2: Table S2. of eEF1BÎł binds the Che-1 and TP53 gene promoters and their transcripts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.